Physician profile
John H Ferguson
NPI 1669682522
$39,961.78
in general payments reported to CMS, 2019-2025
45 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,223 · 2020: $4,213 · 2021: $14K · 2022: $1,400 · 2023: $944 · 2024: $4,906 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $1,599 · Education: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,550.00 |
| Food and Beverage | $1,599.08 |
| Education | $302.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $16,359.53 | 2021-2025 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $15,128.87 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Medical Device Business Services, INC. | $3,696.15 | 2019-2024 | Carto 3 |
| Glaxosmithkline, LLC. | $562.18 | 2019-2025 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $451.67 | 2019-2024 | Ofev |
| Abbott Laboratories | $432.80 | 2019-2025 | Jot Dx |
| Insmed, INC. | $361.39 | 2019-2025 | Arikayce |
| Boston Scientific Corporation | $299.07 | 2019-2022 | |
| Harmony Biosciences LLC | $285.97 | 2023-2025 | Wakix |
| Genzyme Corporation | $228.94 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $159.42 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $154.34 | 2023 | Optimizer |
| Mallinckrodt Hospital Products INC. | $126.11 | 2021-2023 | Acthar |
| Actelion Pharmaceuticals US, INC. | $123.95 | 2019-2025 | Opsumit, Uptravi |
| Pfizer INC. | $106.97 | 2019-2020 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.